Dexamethasone Market – New Opportunity During Covid-19 for Pharma Players?
Zion Market Research has published a new report titled “Dexamethasone Market by Formulation type(liquid, tablet, Solution for injection, Other); by Patient type (Adult, Pediatric, and Geriatric); by Application (Anti-inflammatory and immunosuppressant effects, Respiratory Distress syndrome, COVID-19, and Others); By End user (Hospitals, Clinics, Pharmacy & Drug Stores, Online Pharmacies): Global Industry Perspective, Comprehensive Analysis and Forecast, 2020 – 2026”.
Dexamethasone is a a potent anti-inflammatory synthetic adrenal corticosteroid that prevents substances that cause inflammation into the body. Dexamethasone is used to treat various inflammatory conditions, like allergic disorders, and skin diseases inflammation (swelling), severe allergies, adrenal problems, arthritis, asthma, blood or bone marrow problems, kidney problems, skin conditions, and flare-ups of multiple sclerosis. Dexamethasone can also be used to combat conditions such as colitis, arthritis, lupus, psoriasis and breathing. Dexamethasone mechanism of action is binding to specific receptors of nuclear steroids, dexamethasone also interferes with NF-kB activation and apoptotic pathways. Dexamethasone is an off-patent drug that is distributed as a generic drug and also under the brand name ,which is cost-effective and manufactured by various large and small pharmaceutical companies.
Get Free Sample of this Research Report – https://www.zionmarketresearch.com/sample/dexamethasone-market
The rise of dexamethasone as a lifesaving treatment for critically ill COVID-19 patients due to a sudden outburst, Increasing various inflammatory conditions, and growing prevalence of diseases will act as major driving factors in the growth of global Dexamethasone market. High investment in research and development in Dexamethasone market will act as an opportunity for the market players in the Dexamethasone market. Nonetheless, side effects associated with use of Dexamethasone will restrict the growth of global Dexamethasone market.
The global Dexamethasone market has been fragmented into Formulation type, Patient type, Application, End user, and region. Based on Formulation type, Global Dexamethasone Market is segmented into liquid, tablet, Solution for injection, and Others. Based on Patient type, Market is segmented into Adult, Pediatric, and Geriatric. Based on Application, Market is segmented into Anti-inflammatory and immunosuppressant effects, Respiratory Distress Syndrome, Covid-19, and Others. The End user segment of the Dexamethasone Market is categorized into Hospitals, Clinics, Pharmacy & Drug Stores, and Online Pharmacies.
Region wise, the Dexamethasone market is segmented into North America, Latin America, Asia Pacific, Europe, and the Middle East & Africa. North America will be the leading region during the forecast period. Increasing cases of covid-19, and High prevalence of diseases, will boost the market growth in this region. Europe will be the second largest market. The major reasons are increasing awareness concerning use of Dexamethasone and high impact of pandemics like COVID-19. Asia Pacific will thrive at speedy rate over the forecast period due to high incidences of viral disease outbreak and due to presence of major manufacturers of Dexamethasone in this region. Latin America market will progress at a notable rate during the estimate period. The Middle Eastern and African countries are expected to experience clear growth in the predictable time.
The report also includes detailed profiles of key players such Cadila Healthcare Ltd., Wockhardt Ltd., Dwarkesh Pharmaceuticals Private Limited, Schwitz Biotech, Lexine Technochem Private Limited, Mapro Lifescience, Therawin Formulations, Shervotec Pharmaceuticals, Acichem Laboratories, Quality Nexgen Pharmaceuticals Pvt Ltd ,Kern Pharma SL, Symbiotic Pharma, AuroMedics, Fresenius Kabi, Hikma, Mylan, Somerset Therapeutics, American Regent, Shanghai General Pharmaceutical, Hunan Hansen Pharm, Chengdu Brilliant Pharmaceutical, Cisen Pharmaceutical, CSPC Group, Jiangsu Wuzhong Pharm, Guangzhou Baiyunshan Tianxin Pharmaceutical among others.
Browse more Pharma Industry Reports – https://www.zionmarketresearch.com/category/pharmaceutical
The report segment of global Dexamethasone market as follows:
Global Dexamethasone Market: By Formulation type
- Solution for injection
Global Dexamethasone Market: By Patient type
Global Dexamethasone Market: By Application
- Anti-inflammatory and immunosuppressant effects
- Respiratory Distress Syndrome
Global Dexamethasone Market: By End user
- Pharmacy & Drug Stores
- Online Pharmacies
Global Dexamethasone Market: By Region
- North America
- The U.S.
- The UK
- Rest of Europe
- Asia Pacific
- South Korea
- Southeast Asia
- Rest of Asia Pacific
- Latin America
- Rest of Latin America
- Middle East & Africa
- South Africa
- Rest of Middle East & Africa
Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.
Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651
- CDN Newswire